PDCD1 and neoplasm: Ex vivo data from patient-derived micro-tumors (PDMs) co-cultured with autologous tumor-infiltrating lymphocytes (TILs) corroborate these findings, with the combination of anti-CSF1R and anti-PD-1 promoting cytotoxic activity [44].